Tempus AI, Inc. (TEM) vs TransMedics Group, Inc. (TMDX)

A side-by-side comparison of Tempus AI, Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 4, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnTEM vs TMDX

growth of $100 · dividends reinvested · last 2y
TEM +14.4%TMDX -43.1%TEM compounded faster
50100150200250Start $10020252026$114$57
TEM TMDX

TEM vs TMDX: by the numbers

  • TEM is the larger company ($8.24B vs $2.80B market cap).
  • TMDX is profitable (27.04% net margin) while TEM runs a net loss (-17.77%).
  • TMDX grew revenue faster over the past five years (90.79% vs 38.24% CAGR).

Metrics side by side

Valuation

MetricTEMTMDX
P/E ratioN/A18.66
Forward P/EN/A44.58
P/S ratio5.874.64
P/B ratio18.885.97
PEG ratioN/A0.05
EV / EBITDAN/A26.33
FCF yieldN/A5.13%

Profitability

MetricTEMTMDX
Gross margin63.98%59.09%
Operating margin-19.76%14.85%
Net margin-17.77%27.04%
ROE-57.18%34.80%
ROIC-10.29%10.94%

Growth (annualized)

MetricTEMTMDX
Revenue CAGR (5Y)38.24%90.79%
Total return CAGR (5Y)N/A23.91%

Frequently asked

Which has grown faster, TEM or TMDX?
Over the past five years, TMDX grew revenue faster — TEM at a 38.24% CAGR versus TMDX at 90.79%.
Is TEM or TMDX more profitable?
TMDX runs the higher net margin — TEM at -17.77% versus TMDX at 27.04%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 4, 2026.